協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/03/27 | 1,083 | 1,090 | 1,071 | 1,089 | +16 | +1.5% | 1,233,000 |
| 2013/03/26 | 1,070 | 1,081 | 1,066 | 1,073 | -3 | -0.3% | 1,315,000 |
| 2013/03/25 | 1,080 | 1,083 | 1,071 | 1,076 | +16 | +1.5% | 1,185,000 |
| 2013/03/22 | 1,079 | 1,089 | 1,057 | 1,060 | -19 | -1.8% | 1,749,000 |
| 2013/03/21 | 1,054 | 1,079 | 1,039 | 1,079 | +24 | +2.3% | 2,398,000 |
| 2013/03/19 | 1,033 | 1,057 | 1,033 | 1,055 | +36 | +3.5% | 1,922,000 |
| 2013/03/18 | 1,025 | 1,036 | 1,018 | 1,019 | -25 | -2.4% | 1,560,000 |
| 2013/03/15 | 1,007 | 1,044 | 1,004 | 1,044 | +45 | +4.5% | 2,630,000 |
| 2013/03/14 | 988 | 1,000 | 983 | 999 | +11 | +1.1% | 969,000 |
| 2013/03/13 | 987 | 998 | 984 | 988 | -12 | -1.2% | 1,052,000 |
| 2013/03/12 | 1,004 | 1,011 | 1,000 | 1,000 | -4 | -0.4% | 1,627,000 |
| 2013/03/11 | 1,000 | 1,012 | 996 | 1,004 | +9 | +0.9% | 1,379,000 |
| 2013/03/08 | 987 | 997 | 980 | 995 | +11 | +1.1% | 4,900,000 |
| 2013/03/07 | 990 | 996 | 976 | 984 | -3 | -0.3% | 1,702,000 |
| 2013/03/06 | 970 | 987 | 970 | 987 | +18 | +1.9% | 1,275,000 |
| 2013/03/05 | 978 | 980 | 965 | 969 | ±0 | ±0% | 809,000 |
| 2013/03/04 | 970 | 982 | 966 | 969 | ±0 | ±0% | 1,502,000 |
| 2013/03/01 | 961 | 975 | 961 | 969 | -2 | -0.2% | 1,127,000 |
| 2013/02/28 | 958 | 973 | 956 | 971 | +21 | +2.2% | 1,297,000 |
| 2013/02/27 | 958 | 967 | 947 | 950 | +1 | +0.1% | 1,263,000 |
| 2013/02/26 | 945 | 958 | 941 | 949 | -15 | -1.6% | 1,718,000 |
| 2013/02/25 | 950 | 976 | 950 | 964 | +28 | +3% | 2,103,000 |
| 2013/02/22 | 915 | 940 | 915 | 936 | +27 | +3% | 1,731,000 |
| 2013/02/21 | 912 | 923 | 907 | 909 | +2 | +0.2% | 1,243,000 |
| 2013/02/20 | 900 | 914 | 900 | 907 | +13 | +1.5% | 1,470,000 |
| 2013/02/19 | 888 | 897 | 887 | 894 | -1 | -0.1% | 845,000 |
| 2013/02/18 | 881 | 896 | 879 | 895 | +23 | +2.6% | 1,592,000 |
| 2013/02/15 | 869 | 882 | 869 | 872 | -7 | -0.8% | 945,000 |
| 2013/02/14 | 861 | 880 | 859 | 879 | +8 | +0.9% | 2,234,000 |
| 2013/02/13 | 876 | 880 | 867 | 871 | -7 | -0.8% | 956,000 |
| 2013/02/12 | 868 | 882 | 864 | 878 | +24 | +2.8% | 1,575,000 |
| 2013/02/08 | 857 | 869 | 853 | 854 | -16 | -1.8% | 2,258,000 |
| 2013/02/07 | 868 | 873 | 864 | 870 | -1 | -0.1% | 1,285,000 |
| 2013/02/06 | 860 | 872 | 857 | 871 | +21 | +2.5% | 1,434,000 |
| 2013/02/05 | 852 | 855 | 849 | 850 | -4 | -0.5% | 1,278,000 |
| 2013/02/04 | 859 | 860 | 852 | 854 | -4 | -0.5% | 1,221,000 |
| 2013/02/01 | 868 | 869 | 856 | 858 | -6 | -0.7% | 1,603,000 |
| 2013/01/31 | 868 | 905 | 853 | 864 | -18 | -2% | 3,607,000 |
| 2013/01/30 | 875 | 882 | 871 | 882 | +11 | +1.3% | 1,014,000 |
| 2013/01/29 | 875 | 885 | 869 | 871 | -14 | -1.6% | 1,405,000 |
| 2013/01/28 | 897 | 902 | 883 | 885 | +3 | +0.3% | 1,497,000 |
| 2013/01/25 | 850 | 882 | 848 | 882 | +42 | +5% | 1,879,000 |
| 2013/01/24 | 837 | 843 | 833 | 840 | -2 | -0.2% | 1,600,000 |
| 2013/01/23 | 850 | 857 | 842 | 842 | -15 | -1.8% | 1,338,000 |
| 2013/01/22 | 869 | 869 | 848 | 857 | -7 | -0.8% | 1,172,000 |
| 2013/01/21 | 877 | 881 | 864 | 864 | -11 | -1.3% | 1,040,000 |
| 2013/01/18 | 874 | 879 | 871 | 875 | +6 | +0.7% | 1,306,000 |
| 2013/01/17 | 865 | 871 | 857 | 869 | +9 | +1% | 1,496,000 |
| 2013/01/16 | 874 | 874 | 856 | 860 | -11 | -1.3% | 1,670,000 |
| 2013/01/15 | 893 | 895 | 871 | 871 | -15 | -1.7% | 2,283,000 |
3001～
3050
件表示中 / 3734件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 249,300円 | -3.5% | -11.3% | 2.41% | 22.90倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 139,100円 | +0.9% | +380.2% | 5.61% | 19.15倍 | 1.65倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 250,000円 | +20.9% | +10.6% | 2.64% | 11.82倍 | 1.56倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 411,000円 | +0.1% | -3.4% | 3.89% | 27.94倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 157,500円 | +0.6% | +43.3% | 5.08% | 11.04倍 | 0.95倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
